Measurement of nitric oxide-related amino acids in serum and plasma: effects of blood clotting and type of anticoagulant.
Davids M, Peters JH, de Jong S, Teerlink T
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of anticoagulant type and collecting serum rather than plasma from healthy individuals on amino acid levels. Serum was collected in tubes containing clot activator. A portion of serum and plasma specimens were deproteinized, while others were not, allowing for the use of two different HPLC procedures. All specimens were frozen at -80 degrees C until analysis.
Summary of Findings
7 out of 22 amino acids had slightly (<5.3%) but significantly lower concentrations in EDTA-plasma than in heparin-plasma. 8 out of 22 amino acids had significantly higher concentrations in serum than in heparin-plasma. The differences in amino acid levels tended to be larger between serum and heparin-plasma than between EDTA- and heparin-plasma. Only one amino acid, asparagine, had significantly different concentrations between all three specimen types.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NormalPlatforms
Small moleculeHPLCPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinNonePotassium EDTABiospecimen Aliquots and Components Blood and blood products PlasmaSerum